Chewy, Inc. (NYSE:CHWY) delivered a strong profitability beat in its fiscal second-quarter results, reporting adjusted earnings per share of $0.36, nearly double the approximately $0.18 consensus estimate. The company also posted net sales of $3.33 billion, representing a 7.3% increase year over year. Despite the earnings beat, management noted that the broader pet market did not meaningfully recover during the quarter, prompting a cautious view on consumer spending while still raising the full-year revenue and profitability outlook.

Market Context

The results highlight a divergence between Chewy’s operational execution and the macroeconomic environment. CEO Sumit Singh indicated that while the pet sector did not deteriorate further, it also failed to show a significant recovery. Chewy continues to outperform the category by two to three times through share gains across both established and newer business lines. This performance comes as investors watch for signs of stabilization in discretionary consumer spending, which remains under pressure.

Analysis

Chewy’s ability to beat expectations was driven by a combination of recurring revenue strength and structural cost efficiencies. Autoship sales, a key indicator of customer retention, jumped 9.3% year over year to $2.82 billion, accounting for 84.6% of total net sales. This high percentage of subscription-based revenue provides greater visibility and reduces exposure to fluctuations in discretionary spending. Additionally, Chewy Health delivered triple-digit revenue growth, and specialty categories like equine and exotics saw a seventh consecutive quarter of mid-double-digit growth, diversifying revenue sources.

However, the quality of the earnings beat warrants scrutiny. CFO Chris Deppe revealed that the quarter’s profitability upside included about $10 million from timing benefits and more than $5 million from discrete benefits. These items boosted the latest results but do not provide a recurring earnings contribution, suggesting that investors may need to temper expectations for the pace of margin expansion in future quarters. Furthermore, core organic growth has slowed, with revenue excluding recent acquisitions rising 5.7%, down from 7.7% in the first quarter. Management does not expect a real recovery in consumer spending to support the 2026 outlook, indicating that future growth will rely heavily on market share gains and category expansion rather than sector tailwinds.

Key Numbers

- Net Sales: $3.33 billion (+7.3% YoY)

- Adjusted EPS: $0.36 (vs. ~$0.18 expected)

- Autoship Sales: $2.82 billion (+9.3% YoY), 84.6% of total net sales

- Net Active Customers: 21.7 million (+208,000 during the quarter)

- Shareholder Returns: $200 million via share repurchases

- Organic Revenue Growth (ex-acquisitions): 5.7% (down from 7.7% in Q1)

- Non-Recurring Profit Items: ~$15 million combined from timing and discrete benefits

What to Watch

Traders should monitor whether Chewy can maintain its share gains in a flat pet market. Key metrics to watch include the sustainability of margin expansion once the non-recurring timing and discrete benefits roll off, as well as the trajectory of organic growth in subsequent quarters. The performance of Chewy Health and specialty categories will be critical in offsetting the deceleration in core retail growth. Additionally, investors will look for any changes in guidance regarding consumer spending recovery in the latter half of 2026.